Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Consumer Health


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards

General Health : Drug News Last Updated: Aug 1, 2008 - 10:24:18 AM


Medication harms Alzheimer's patients
By Sue Mueller
Mar 31, 2008 - 10:45:21 PM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   
MONDAY March 31, 2008 (foodconsumer.org) -- Anti-psychotic drugs given to advanced Alzheimer's patients with mild behavioral problems provide no benefit, but cause a significant deterioration in verbal skills, according to a UK study published in the journal Public Library of Science Medicine.

The study involved 165 people with advanced Alzheimer's who were living in nursing homes in Oxfordshire, Newcastle, Edinburgh and London.  Up to 60 percent of Alzheimer's patients in nursing homes were given neuroleptics to control their behavior.

Researchers from King's College London and the Universities of Oxford and Newcastle found the drugs delivered no long term benefit for most patients with mild symptoms of disturbed behaviors.  

In fact, the anti-psychotic drugs caused a marked deterioration in their verbal fluency after six months of treatment.  An analysis of the data suggests that use of neuroleptics may also increase risk of death.

Early studies have also found use of anti-psychotic drugs raised the risk of stroke and death for patients with dementia.

In the study, all patients had been given neuroleptics for three months. Then they either continued taking the same medication for another12 months, or started taking a placebo.  

The drugs used in the study included hioridazine (Melleril), chlorpromazine (Largactil), haloperidol (Serenace), trifluoperazine (Stelazine) and risperidone (Risperdal).

Clive Ballard, lead author of the study said, according to BBC, as short as six-months of treatment would cause harm Alzheimer's patients with mild behavioral problem, suggesting that neuroleptics should not be used to treat mild symptoms.

But for people with severe behavioral symptoms, balancing the benefits against adverse effects of the anti-psychotic drugs is not easy.  

The Alzheimer's Research Trust in the UK was cited as saying that neuroleptics should only be prescribed long-term to dementia patients with sever behavioral problems and they should be used only as a last resort when non-drug management has been tried and failed.

from BBC NEWS





© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites














disclaimer | advertising | jobs | privacy | abou t us | newsletter | Submit news/articles
link partners: | shopseek.com | infoplus.com | foodregister.com | uscards.com | beyondcreditcards.com | DaytonaCPA.com |
Get Google Ads Free | Download Movies | Search Public Records | Stock Trading Robot
Satellite for PC | Let Your Car Burn Water | The Affiliate Conspiracy | Run a Car on Water
Top Movie Downloads | Reverse Phone Detective | Get Paid for Surveys | Fat Loss 4 Idiots

© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.